| Literature DB >> 3800325 |
P Preusser, H Wilke, W Achterrath, B Neuhaus, L Balleisen, J Meyer, J Van de Loo.
Abstract
In a pilot study 16 patients with advanced inoperable stomach cancer were treated with Etoposide, Adriamycin, Cisplatin. The recommended dose for phase II studies was established and first therapy results are presented. Two of 16 patients responded with complete remissions and 8 with partial remissions. The recommended dose schedule for phase II studies is: Adriamycin 20 mg/m2 i.v. day 1 + 7; Cisplatin 40 mg/m2 i.v. day 2 + 8; Etoposide 120 mg/m2 i.v. day 4, 5, 6, every four weeks.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3800325
Source DB: PubMed Journal: Anticancer Res ISSN： 0250-7005 Impact factor: 2.480